article thumbnail

Breaking ICD Codes: Identifying Ambiguous Respiratory Infection Codes via Regional Diagnosis Heterogeneity [Original Research]

Annals of Family Medicine

METHODS We analyzed national weekly diagnosis data for acute respiratory infections (ICD-10 codes J00-J22) in Poland from 2010 to 2019, covering all 380 county-equivalent administrative regions and encompassing 292 million consultations. Data were aggregated into age brackets.

Diagnosis 130
article thumbnail

Agitation Podcast Series Episode 1: Differentiating organic versus psychiatric causes of agitation and altered mental status

PEMBlog

Most children who present to Pediatric Emergency Departments these days with mental health concerns – including agitation – have a known psychiatric problem or diagnosis. Government. Pediatr Radiol 2019; 49:240. 2019 Mar;20(2):409-418. 2019 Mar;20(2):409-418. Epub 2019 Feb 19. 2019 May;20(3):537.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. His job was governed by an employment contract that contained both salary provisions and restrictive covenants.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. His job was governed by an employment contract that contained both salary provisions and restrictive covenants.

article thumbnail

CMS Publishes Grab Bag of Proposed Changes to the Medicaid Drug Rebate Program

FDA Law Blog

Kirschenbaum — Last Friday, May 26, CMS published in the Federal Register an assortment of proposals to change the regulations governing the Medicaid Drug Rebate Program. This limitation is virtually unenforceable because prescriptions and Medicaid claims for drugs do not identify the patient’s diagnosis or condition. See 42 U.S.C.

article thumbnail

The Promise and Pitfalls of AI in Medicine: Guest Bob Wachter

GeriPal

Alex: In 2019 … You wrote two viewpoints about AI recently in JAMA, relatively recently. I guess, 2019, and then, one again about last month or so. And what I want to do is, this is a tough task for you, I’m sure, but I have a patient with a new diagnosis of cancer, and it’s actually a 35-year-old woman.